Final Program

TUESDAY • MAY 17 317
C87
BASIC
PUBLIC ADVISORY ROUNDTABLE
CME Credits Available: 2.0
NEW INSIGHTS INTO THE GENETIC BASIS OF
PEDIATRIC LUNG DISEASE
Public Advisory Roundtable; Assembly on Pediatrics
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3007/3009 (West Building, Level 3)
Target Audience
Physicians, basic and translational scientists, clinician-investigators, nurses,
patients, and parents.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the genetics of interstitial lung diseases in neonates and children,
and how this information is providing new insights into pathogenesis, improved
diagnostic tests, and potential therapeutic targets;
• appreciate the emerging genetics of primary ciliary dyskinesia and importance
as a diagnostic approach, and understand genotype-phenotype relationships in
this disease;
• recognize the importance of genetics in the pathophysiology of cystic fibrosis
lung disease, and how this knowledge has led to the development of precision
medicine.
The emergence of powerful, more affordable genomic technologies have advanced
our knowledge of lung diseases at a rapid pace, providing greater insights into the
genetics and pathophysiology of pulmonary diseases in children and adults. The
progress made in genomics will increasingly translate into improved patient health,
with improved diagnostic tests and personalized therapies. This session will highlight
the progress made in genomics of lung diseases, focusing on the genetic and
cellular bases of four childhood diseases, which will serve as a roadmap for other
conditions.
Chairing: G.R. Porta, BS, Mason, OH
T.W. Ferkol, MD, St. Louis, MO
2:15 Annual PAR Awards
G.R. Porta, BS, Mason, OH
2:30 Introduction
T.W. Ferkol, MD, St. Louis, MO
2:35 Neonatal Lung Diseases
F.S. Cole, MD, St. Louis, MO
3:00 Cystic Fibrosis
G.R. Cutting, MD, Baltimore, MD
3:25 Primary Ciliary Dyskinesia
M. Knowles, MD, Chapel Hill, NC
3:50 Childhood Interstitial Lung Diseases
L.M. Nogee, MD, Baltimore, MD
C88
CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
VIRAL COMMUNITY-ACQUIRED PNEUMONIA
Assemblies on Microbiology, Tuberculosis and Pulmonary Infections;
Clinical Problems; Critical Care; Pediatrics
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3016/3018 (West Building, Level 3)
Target Audience
Pulmonologists, critical care specialists, pediatricians, scientists, hospital
administrators, medical providers, trainees, fellows, and advanced practice
providers.
Objectives
At the conclusion of this session, the participant will be able to:
• understand and learn about recent epidemiological data on respiratory viruses as
etiology of community acquired pneumonia;
• learn new diagnostics tools to detect viral infection, including understanding the utility of
procalcitonin in clinical medicine;
• understand how to integrate new information on respiratory viruses into clinical practice.
This session will provide the learner a comprehensive overview on how respiratory viruses
contribute to current causes of community acquired pneumonia (CAP) and acute lung
injuries in the ICU especially in the setting of the increasing use of genetic-based diagnostic
approaches to detect viruses. Speakers in this symposium will highlight the current
epidemiology of viral CAP and review the existing diagnostics of viral CAP including a
pro/con debate on the role of procalcitonin in viral pneumonia. The role of viral pneumonia as
cause of ARDS, and how RSV contributes to the disease in children and the elderly will be
explored. And finally, given the increased use of molecular diagnostics to detect respiratory
viruses, there will be a timely and careful discussion on what to do with a positive respiratory
virus panel, including an analysis of whether rhinovirus ever causes pneumonia. These
series of talks will update the audience on the recent information on viral pneumonia in
clinical medicine with the goal of improving not only understanding of this topic but better
implementation of current knowledge on viral pneumonia into practice.
Chairing: C.S. Dela Cruz, MD, PhD, New Haven, CT
R.D. Shah, MD, Chicago, IL
2:15 Epidemiology of Viral CAP
W. Self, MD, MPH, Nashville, TN
2:35 Pro/Con Debate: Procalcitonin for Viral Pneumonia (Con)
G.W. Waterer, MBBS, PhD, MBA, Perth, Australia
2:50 Pro/Con Debate: Procalcitonin for Viral Pneumonia (Pro)
T. File, MD, Akron, OH
3:05 RSV in the Young and Old Patients
J. Devincenzo, MD, Memphis, TN
3:25 Viral Pneumonia and ARDS: A Lethal Combination
J.E. Chastre, MD, Paris, France
3:45 What to Do with a Positive Respiratory Virus Panel (RVP)?
R.G. Wunderink, MD, Chicago, IL
4:05 Discussion
C.S. Dela Cruz, MD, PhD, New Haven, CT
There will be a 5-minute discussion after each talk.
TUESDAY AFTERNOON
ATS 2016 • San Francisco